Analystreport

Evogene Ltd. (NASDAQ: EVGN) had its price target lowered by analysts at Roth Capital from $6.00 to $3.00.

Evogene Ltd. - Ordinary Shares  (EVGN) 
Last evogene ltd. - ordinary shares earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: evogene.com/investor-relations